Allakos is throwing in the towel. After seeing phase 1 data in hives, the biotech has decided to drop the drug candidate and ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Allakos (NASDAQ:ALLK) has dropped ~75% in premarket trading Monday after posting disappointing phase 1 results on AK006 for chronic spontaneous urticaria and deciding to end development. Due to ...

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

UEFA.com delves into the UEFA Champions League archive to unearth some memorable encounters from the last matchday of the ...

A significant milestone was reached on Friday afternoon with the opening of the second completed section of the Monon South ...

The knockout phase play-off draw for the 2024/25 UEFA Champions League takes place from 12:00 CET on Friday 31 January. Check out the draw timings where you are thanks to Hublot, Official Timekeeper ...

Israel says a Hamas list shows that eight of the 33 hostages to be released in the first phase of the Gaza ceasefire are ...

Donald Trump launched a two-year trade war against China during his first term in the White House, and he’s poised to do it ...

Fortress Biotech (NASDAQ:FBIO)'s Chairman and CEO, Dr. Lindsay (NYSE:LNN) A. Rosenwald, expressed optimism about the vaccine's role in preventing and treating CMV in the future. While analysts ...

Thailand's economy is expected to grow between 3% and 3.5% this year, driven by stimulus measures and strong foreign ...